医学
射血分数
乳腺癌
辅助化疗
化疗
内科学
心脏病学
佐剂
癌症
肿瘤科
心力衰竭
作者
Riya Garg,Ralph B. D’Agostino,Nathaniel S. O’Connell,Glenn J. Lesser,Fadi N. Salloum,Anika L Hines,Giselle C. Meléndez,Jennifer H. Jordan,Bonnie Ky,Lynne I. Wagner,Arnethea L. Sutton,Wendy Bottinor,Kristine C. Olson,Amy C. Ladd,W. Gregory Hundley
出处
期刊:Hypertension
[Lippincott Williams & Wilkins]
日期:2024-04-18
卷期号:81 (6): 1365-1373
被引量:2
标识
DOI:10.1161/hypertensionaha.123.21817
摘要
Hypertension is a risk factor for experiencing left ventricular ejection fraction (LVEF) declines during receipt of potentially cardiotoxic breast cancer (BC) treatment. We sought to determine whether the hypertension stage is associated with LVEF decline during BC treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI